Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 751 - 800 out of 3,268

Document Document Title
WO/2003/004507A1
The invention involves a kind of oligosaccharides and their sulfates. The backbone of the oligosaccharides is consisting of 3 to 14 sugar residues, and the side chains are consisting of 0 to 4 sugar residues. There is at least one 1 →$...  
WO/2002/103008A2
The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of...  
WO/2002/103038A1
The invention relates to an enzymatic method of producing 4-0-$g(b)-D-galactopyranosyl-D-xylose which is used for the in vivo evaluation of intestinal lactase activity in humans. The inventive method consists in: a) reacting D-xilose wit...  
WO/2002/091859A1
The invention provides an agent that heightens concentration and attentiveness and sustains concentration and attentiveness for a longer period of time and more constantly. It also provides food and drink that contains the agent that sus...  
WO/2002/089742A2
The presently claimed and disclosed invention relates, in general, to dual action heparin synthases and, more particularly, to dual action heparin synthases obtained from Pasteurella multocida. The presently claimed and disclosed inventi...  
WO/2002/088155A1
The present invention relates to the production of xylitol. In particular, processes utilising L-xylose as an intermediate for xylitol production are described. The present invention also relates to process for the preparation or L-xylos...  
WO/2002/088154A1
The present invention relates to process for the preparation or L-xylose, as an intermediate, by-product or end-product to be used per se. Further processes utilising L-xylose as an intermediate for xylitol production are described.  
WO/2002/083701A1
A means for inhibiting decomposition products, isomerization products, colored substances, etc. from generating in the desalting of a sugar solution and for thereby inhibiting the generation of impurities and preventing an ion-exchange r...  
WO/2002/076195A1
The subject invention pertains to a transgenic animal model for tumorigenesis having a genome comprising a ras transgene and which is heterozygous or homozygous for a null p27 gene, and methods of using such animal to screen compounds or...  
WO/2002/072594A1
A novel glycosyl derivative which is a cyclic tetrassacharide represented by cyclo{$m(7)6)-$g(a)-D-glucopyranosyl-(1$m(7)3)-$g(a)-D-gluco pyranosyl-(1$m(7)6)-$g(a)-D-glucopyranosyl-(1$m(7)3)-$g(a)-D -glucopyranosyl-(1$m(7)}. It is a bran...  
WO/2002/066496A1
A modifier characterized by containing as the active ingredient a compound represented by the formula (I) (wherein X is OH, OSO¿3?H, or OCH¿3? and R is a substituent excluding OH). The modifier is applied to a substance having reactivi...  
WO/2002/058633A2
Described is a modular, general synthetic strategy for the preparation in solution and on a solid support of heparin, heparin-like glycosaminoglycans, glycosaminoglycans and non-natural analogs of each of them. Additionally, the modular ...  
WO/2002/059300A2
The present invention relates to methods for modifying gene expression and in particular to methods for controlling gene expression in eukaryotic cells using double-stranded RNA (dsRNA), and to eukaryotic cell lines in which gene express...  
WO/2002/056893A1
The present invention describes a substance or a receptor comprising $i(Helicobacter pylori) binding oligosaccharide sequence [Gal(A)¿q?(NAc)¿r?/Glc(A)¿q?(NAc)¿r?$g(a)3/$g(b)3]¿s?[G al$g(b)4GlcNAc$g(b)3]¿t?Gal$g(b)4Glc(NAc)¿u? whe...  
WO/2002/057011A1
A dehydrating agent comprising a cyclic tetra-saccharide, which is defined in the specification, as an effective component; a method for dehydrating a moist article, characterized in that the moist article is incorporated into, is contac...  
WO/2002/053783A1
The invention relates to a process of producing a xylose solution from a biomass hydrolysate by subjecting the biomass hydrolysate to nanofiltration and recovering as the nanofiltration permeate a solution enriched in xylose. The biomass...  
WO/2002/051264A2
A nutritional composition having beneficial effect in the gastrointestinal tract, especially an anti-adhesion effect on pathogenic micro-organisms and a bifidogenic effect, contains non-digestible oligosaccharides, said oligosaccharides ...  
WO/2002/050089A1
The present invention relates to improved methods of purification of sugars and in particular to a method of preparing lactose. A low purity lactose source such as whey is subjected to a first demineralisation step involving either ion-e...  
WO2000052018A9
In certain embodiments, the present invention relates to versatile linkers for tethering a molecule to a solid support, e.g. for tethering a monomer, oligomer or polymer to a solid support, which are stable to a wide range of reaction co...  
WO/2002/050257A2
The invention relates to nucleic acids coding for modified polypeptides with fructosyltransferase activity, the vectors containing said nucleic acids for the expression of the modified fructosyltransferase in prokaryotic or eukaryotic ce...  
WO/2002/048163A2
Disclosed are novel synthetic processes for the preparation of $g(a)Gal(1$m(7)4) $g(b)Gal(1$m(7)4)Glc-OR trisaccharides.  
WO/2002/044194A1
A novel process for preparing 2,2'-anhydro-1-(ß-L- arabinofuranosyl)thymine which is novel and a useful intermediate; a novel process for preparing L-thymidine from 2,2'-anhydro-1-(ß-L-arabinofuranosyl)thymine; and a novel process for ...  
WO/2002/044190A2
Disclosed are novel synthetic processes for preparation of the trisaccharide $g(a)Gal(1$m(7)3)$g(b)Gal(1$m(7)4)Glc-OR compounds.  
WO/2002/036600A2
In a composition comprising a therapeutic agent and a compound which is a trisaccharide or higher polysaccharide, that compound has the formula X[-Y-Z]¿n? wherein X and Z are each saccharide molecules in which none, some or all OH group...  
WO/2002/032914A2
Acylated cellobiose compounds (CHME) which satisfy the formula:- wherein X represents an acyl group (R-CO-) or H, Z represents an acyl group (R'-CO-) or H and not more than a minority of X + Z residues represent H, R represents a saturat...  
WO/2002/027039A1
The present invention relates to a method for recovering a monosaccharide selected from the group consisting of rhamnose, arabinose, xylose and mixtures thereof from a solution containing the same by a multistep process using chromatogra...  
WO/2002/027037A1
The invention relates to a method comprising a multistep process for recovering betaine, erythritol, inositol, sucrose, mannitol, glycerol and amino acids from corresponding starting materials. The invention comprises the use of a weakly...  
WO/2002/026701A2
Ionic compounds with a freezing point of up to 100 °C are formed by the reaction of an one amine salt of formula (I) R?1¿ R?2¿ R?3¿ R?4¿ N?+¿ X?-¿, such as choline chloride with an organic compound (II) capable of forming a hydrog...  
WO/2002/024832A1
The invention aims at providing a method for protecting unsaturated compounds from chemical changes due to radical reactions by inhibiting the conversion of unsaturated compounds into radicals. This aim is attained by an aggregate-formin...  
WO/2002/020712A1
The invention is directed to a brewing process for making a fermented product having an increased dietary fibre content and to a fermented product having an increased content of soluble dietary fibre.  
WO/2002/018449A1
The present invention provides a new class of compounds presenting a high compatibility with tissues and organic fluids. Such new compounds are polysaccharides essentially formed of units of uronic acid and/or hexosamine, containing nitr...  
WO/2002/018603A1
Isomaltulose synthase (sucrose, EC 5.4.99.11) converts surcrose to isomaltulose (6-O-$g(a)-D-glucopyranosyl-D-fructofuranose). The enzyme has been isolated from Erwinia rhapontici and an additional bacterial isolate 68J. Also disclosed a...  
WO/2002/016384A2
One aspect of the present invention relates to an apparatus for the efficient synthesis of oligosaccharides on a solid support, e.g., formed by subunit addition to terminal subunits immobilized on solid-phase particles. In certain embodi...  
WO/2002/016438A2
A tailor-assembly approach is employed for synthesis of complex carbohydrates wherein a polysaccharide is degraded and the shorter product obtained from the degradation is subjected to enzymatic modification to add a sugar moiety. The pr...  
WO/2002/012257A1
A process for producing crystalline tagatose from an aqueous system containing no organic solvents. The process comprises adding seed tagatose crystals to a tagatose solution which has a solid concentration of 60 to 98 wt.% and in which ...  
WO/2002/010361A1
$g(a)-Isomaltosylglucosaccharide synthase capable of transferring a-glucosyl from a saccharide, which carries an $g(a)-glucosyl bond as the binding manner at the nonreducing end and has a degree of glucose polymerization of at least 2, w...  
WO/2002/007778A1
The present invention relates to a composition for determining the lactase activity in a mammal. By means of the composition the lactase activity of a mammal, in particular a human being, can be determined in a manner that causes little ...  
WO/2002/008239A1
The invention relates to novel disaccharides of formula (I), wherein R?1¿ is selected from the group consisting of hydrogen, linear or branched (C¿1?-C¿4?) alkyl, phenylalkyl with less than ten carbon atoms and -COCH¿3?; R?2¿ is sel...  
WO/2002/008238A1
A crystalline mannose which contains substantially no organic solvent, has a melting point of 133 to 135 ° as measured by the DSC measurement and has a purity of 96 % or more. The crystalline mannose can be produced by a method which co...  
WO/2002/002150A2
Methods are described for conjugating radioiodinated peptides to non-metabolizable carbohydrates with improved yields and qualities of conjugates. Radioiodinated residualizing antibody conjugates comprising a carbohydrate-appended peptid...  
WO/2002/002581A1
Molasses-containing maltitol crystals which, when pulverized and classified so as to give a powder at least 70 wt.% of which is accounted for by 16- to 50-mesh particles, has an oil absorption of 0.1 to 6.9 wt.% and a bulk density of 0.6...  
WO/2001/097819A1
The present invention is directed to human influenza virus binding substance containing at least one oligosaccharide chain, which comprises a terminal NeuNAc$g(a)6 linked to: (a) a linear or branched polylactosamine type structure consis...  
WO/2001/096281A1
Double fumarates of L-carnitine or isovaleryl L-carnitine and an amino acid are disclosed which are useful as active ingredients of food supplements, dietary supplements or drugs.  
WO/2001/095915A1
A health food/dietary supplement is disclosed suitable for enhancing muscular energy metabolism, comprising as its characterising active ingredients an alkanoyl L-carnitine and ribose.  
WO/2001/094367A1
Substances which hinder human $g(a)-amylase potently and are effective in the prevention and treatment of hyperglycemia such as diabetes and diseases due thereto; and $g(a)-amylase inhibitors and preventive or therapeutic drugs for hyper...  
WO/2001/094356A1
An aqueous solution containing an alkali metal salt of a partial alkyl ester of phosphoric acid wherein the alkyl groups may be each linear or branched and have 16 to 22 carbon atoms on the average, the degree of phosphorylation is 0.6 t...  
WO/2001/090299A2
A novel saccharide which is free from carbon-carbon double bond and carbonyl, is represented by the molecular formula: C6H10O5, and exhibits in high-performance liquid chromatography a retention time of 11.0 ± 0.2 min as determined by u...  
WO/2001/090338A1
$g(a)-Isomaltosyltransferase capable of forming a cyclic tetrasaccharide having a cyclo { - 6} -$g(a)-D-glucopyranosyl- (1 - 3) -$g(a)-D-glucopyranosyl- (1 - 6) -$g(a)-D-glucopyranosyl- ( 1 - 3) -a-D-glucopyranosyl- ( 1 - ) structure via...  
WO/2001/085745A1
Compounds having a mimetic or antagonistic property of an inositol phosphoglycan, and the uses of these compounds are disclosed, together with the use, e.g. to treat a condition ameliorated by administration of an IPG second messenger or...  
WO/2001/083564A1
Soluble amphiphilic macrocycle analogues having lipophilic groups attached to one side of the units making up the macrocycle and hydrophilic groups attached to the other side. These amphiphilic macrocyclic derivatives have the ability to...  

Matches 751 - 800 out of 3,268